Veru Inc. (VERU)

Veru signs a clinical supply agreement for Novo Nordisk’s Wegovy in its Phase 2b PLATEAU obesity study combining enobosarm with a GLP‑1 RA, while retaining global rights.

See the latest Veru stock price NASDAQ: VERU stock rating, related news, valuation, dividends and more to help you make your investing decisions.

Shares of Veru Inc. (NASDAQ: VERU) soared more than 160% during Thursday morning trading after the company announced a clinical supply agreement with Novo

During the last market session, Veru Inc.’s stock traded between $3.020 and $3.190. Currently, there are approximately 23.05 million shares outstanding for Veru Inc.. Veru Inc.’s trailing earnings per share are negative, so the stock does not have a meaningful P/E ratio.

Get real-time Veritone Inc (VERI) stock price, news, financials, community insights, and trading ideas. Join 10 million+ investors and traders tracking markets in real-time on Stocktwits.